{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"13.1","upperLimit":"20.9","value":"16.8"},{"groupId":"OG001","lowerLimit":"7.4","upperLimit":"17.1","value":"11.6"}]}]}],"denomUnitsSelected":"Participants","denoms":[{"counts":[{"groupId":"OG000","value":"382"},{"groupId":"OG001","value":"189"}],"units":"Participants"}],"description":"Durable disease control rate (DDCR) is defined as the percentage of participants with best response of complete response (CR), partial response (PR), or stable disease (SD) of ≥ 6 months duration","dispersionType":"95% Confidence Interval","groups":[{"description":"Tremelimumab 10mg/kg","id":"OG000","title":"TREMELIMUMAB"},{"description":"Placebo.","id":"OG001","title":"PLACEBO"}],"paramType":"NUMBER","populationDescription":"ITT population","reportingStatus":"POSTED","timeFrame":"Time from randomization to disease progression or death, whichever occurs first, assessed up to 3 years.","title":"Durable Disease Control Rate by Treatment Arm","type":"SECONDARY","typeUnitsAnalyzed":"Participants","unitOfMeasure":"Percentage"}